Clinical Trials Search
Clinical Trial 21056
Cancer Type: Malignant Hematology
Study Type: Treatment
NCT#: NCT04623541
Phase: Phase I/II
Principal Investigator: Sandoval-Sus, Jose
Study Title
A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia
Summary
Objective
Therapies
Medications
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
